Anavex Life Sciences (AVXL) Other Non-Current Assets (2016 - 2018)
Anavex Life Sciences (AVXL) reported Other Non-Current Assets of $52396.0 for Q3 2018, little changed on a YoY basis from $52396.0 in Q3 2017, and little changed sequentially from $52396.0 in Q2 2018.
Anavex Life Sciences (AVXL) Other Non-Current Assets (2016 - 2018) Analysis & Trends
Anavex Life Sciences (AVXL) has 3 years of Other Non-Current Assets data on file, last reported at $52396.0 in Q3 2018.
- For the quarter ending Q3 2018, Other Non-Current Assets changed 0.0% year-over-year to $52396.0; the trailing twelve-month figure through Sep 2018 stood at $52396.0 (changed 0.0% YoY), and the FY2018 full-year result was $52396.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $52396.0 in Q3 2018, from $52396.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $52396.0 in Q3 2016 to a low of $52396.0 in Q3 2016.
- A 3-year average of $52396.0 and a median of $52396.0 in 2016 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
- Tracing AVXL's Other Non-Current Assets over 3 years: stood at $52396.0 in 2016, then changed by 0.0% to $52396.0 in 2017, then changed by 0.0% to $52396.0 in 2018.
- Business Quant data shows AVXL's Other Non-Current Assets at $52396.0 in Q3 2018, $52396.0 in Q2 2018, and $52396.0 in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - | 14.48 Mn |
| 10 | Anavex Life Sciences | 222.13 Mn | 90.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 52,396.00 |
| Jun 30, 2018 | 52,396.00 |
| Mar 31, 2018 | 52,396.00 |
| Dec 31, 2017 | 52,396.00 |
| Sep 30, 2017 | 52,396.00 |
| Jun 30, 2017 | 52,396.00 |
| Sep 30, 2016 | 52,396.00 |